EW vs LIN · P/E 47, rev $1.39B vs P/E 34, rev $33.99B
Edwards Lifesciences Corp (EW) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
EW currently screens at market cap $49.91B and trailing P/E 46.9. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the EW and LIN stock pages for the full models.
Not investment advice.